Terpenology Conditions
Record No. 15Pennsylvania Medical Cannabis

Pennsylvania Serious Medical Condition

PTSD

What the research actually supports, and what it does not.

Pennsylvania program
Qualifying condition
Cannabinoid evidence
Human clinical trial A
human trials, weak and mixed; the best one was negative
Terpene evidence
No evidence found F
no study, in humans or animals
Fit score confidence
Very low
Terpenes examined
Linalool, Limonene, Caryophyllene

PTSD is a qualifying condition in Pennsylvania, and it is also the place where the honest answer is hardest to sit with: the best controlled trial of cannabis for PTSD found it worked no better than placebo, and no terpene has ever been tested for it at all.

What patients are managing

PTSD is a qualifying condition under Pennsylvania's medical program, and many patients arrive having already found that cannabis quiets the hyperarousal, the sleeplessness, and the nightmares, at least in the moment. That lived experience is real and it is worth respecting. It is also not the same thing as a treatment that has been shown to work under trial conditions, and this page is about the gap between the two.

What the research supports: cannabinoids

There is a coherent mechanism here. People with PTSD tend to show lower anandamide, one of the body's own cannabinoids, and that signal is central to how fear memories get extinguished, which is why cannabinoids are a reasonable thing to study. But the strongest study is sobering. The first randomized, placebo-controlled trial, eighty US veterans with chronic PTSD across high-THC, balanced, high-CBD, and placebo arms, found no significant difference between any cannabis group and placebo. Everyone improved. Separately, nabilone, a synthetic THC, reduced trauma nightmares in a very small crossover trial, which is a narrow and genuine positive signal for one specific symptom.

Worth knowing before you buyHigh-THC products can worsen the very things PTSD patients are trying to quiet: anxiety, paranoia, and disrupted sleep. Cannabis use disorder is also more common in this population and can pull focus from trauma-focused therapy, which remains the treatment with the strongest evidence. If cannabis is part of your picture, it belongs alongside professional care, not in place of it.

What the research supports: terpenes

This section is short because the evidence is. No human or animal study has tested an individual terpene, linalool, limonene, caryophyllene, or any other, as a treatment for PTSD or its symptoms. Any terpene rationale you see for PTSD is borrowed from the general anxiety or sleep literature and quietly relabeled. That borrowing is exactly what this app refuses to do.

What the research does not support

There is no terpene-specific PTSD evidence of any kind, and the best controlled cannabis trial was negative. A confident PTSD Fit score built on a terpene profile would be inventing a result that does not exist. The narrow real signal, nabilone for nightmares, is a synthetic cannabinoid Terpenology does not score, tested in a handful of people. Anyone selling you a terpene as a PTSD treatment is guessing, and not telling you they are guessing.

How Terpenology scores this

Terpenology holds any PTSD Fit score to very low confidence and says plainly that terpene evidence here is absent, not merely thin. If a product scores at all, it is on the borrowed logic of general calm and sleep, flagged as exactly that. What the app will not do is dress up an anxiety extrapolation as PTSD science, or steer you away from the trauma-focused care that actually has the evidence.

Terpenes worth reading about

Linalool · Limonene · Caryophyllene

Terpenology is educational, not medical advice. Terpene effects are tendencies commonly reported by patients and early research, never guaranteed outcomes. Nothing here is a substitute for the care of your certifying physician, your pharmacist, or the specialist treating your condition.

Terpenology
Medicate Smarter, Not Harder™